How to Verify a Bile Acid Supplier Before You Order
Share
Generic API supplier-verification checklists fall apart on bile acids. Not because the advice is wrong — because it assumes two things that are usually false in this category: that the substance has a pharmacopoeial monograph, and that you are dealing with a manufacturing site.
Most bile-acid offers you will receive are neither. The material is animal-derived, the traded grades often have no monograph to be tested against, and the party quoting you is frequently a trading company with a document package rather than a plant with a quality system. So verification in this category is less about auditing a facility and more about reading a paper trail for the places where it stops.
This is a checklist for that. It covers what each document actually proves, how to read a certificate of analysis line by line, and the failure patterns that repeat often enough to be worth naming.
Why the standard checklist does not transfer
Two structural facts separate bile acids from the average API enquiry.
The first is animal origin. Bile acids start from bile, which is collected as a by-product of slaughter. That introduces a sourcing chain — species, tissue, country of origin, and the health status of the source animals — and a set of documentation obligations around transmissible spongiform encephalopathy risk that has no analogue for a synthetic molecule. A supplier can have flawless analytical paperwork and still have nothing to say about where the bile came from.
The second is the monograph gap. Ursodeoxycholic acid and chenodeoxycholic acid are monographed — in the European Pharmacopoeia and, separately, in the United States Pharmacopeia. Several of the intermediates and derivatives that trade actively are not. When there is no monograph, there is no compendial acceptance criterion for anyone to meet, and "EP grade" becomes a phrase without a definition.
Put those together and the verification question changes shape. It is not "does this supplier meet a standard?" It is "what is this supplier actually able to prove, and are the gaps stated or hidden?"
The document set, and what each one actually proves
Suppliers in this category send a fairly consistent bundle. The list below is not a list of things to collect — it is a list of things to interpret. Every one of them has a limit, and the limits are where buyers get caught.
| Document | What it proves | What it does not prove |
|---|---|---|
| Certificate of analysis, batch-specific | That certain tests returned certain results on the batch named on the sheet | That the method used could have detected what it did not find; that the batch on the sheet is the batch in the drum |
| Specification sheet | The supplier's own acceptance criteria | Compliance with any pharmacopoeia, unless the sheet names one and the values match it |
| Safety data sheet | Hazard classification and handling requirements | Anything at all about quality or identity |
| Residual-solvent statement | Which solvents are controlled and to what level, per batch | That the analysis was done on your batch rather than inherited from the process description |
| Animal-origin / TSE-BSE statement | Species, tissue and country of origin; the supplier's risk position | The absence of contamination, or that the species on the statement matches every other document |
| Traceability documentation | A claimed chain from source material to finished batch | That the chain is complete, or who actually manufactured the material |
| CEP or DMF, where one exists | That a regulatory filing exists for a monographed substance, at a named site | Anything about the quality of the batch in front of you |
Read the right-hand column twice. It is the part that matters. Every document in this bundle is easy to produce and easy to mistake for assurance, and none of them closes the loop on its own.
Where we stand on each of those documents
It would be strange to hand you a verification framework and then leave you to guess how the publisher scores against it. So here is ours, stated plainly, including the parts that are not available.
| Item | Status | Note |
|---|---|---|
| Certificate of analysis | With every batch | Issued against the specific batch supplied |
| Specification sheet | On request | Stated as the supplier's in-house criteria, not as a pharmacopoeial grade |
| Safety data sheet | On request | — |
| Residual-solvent information | On request | Where the manufacturing site reports it; we will say when it is not available |
| Animal-origin / TSE-BSE statement | On request | Obtained from the manufacturing site |
| Traceability documentation | On request | Scope depends on the product; we will tell you its extent rather than overstate it |
| GMP certificate in our name | Not held | JAN Bio is not a manufacturing site. Certificates, where they exist, sit with the plant |
| CEP or DMF in our name | Not held | Held, if at all, by the manufacturing site for the substances that have a monograph |
Two rows say "not held." That is deliberate. A trading partner that presents itself as a manufacturing site is telling you something about how it will handle every other question, and it is not a good sign. Where a certificate exists we will name the site it belongs to. Where it does not, we will say so rather than let the brochure fill the space.
Reading a certificate of analysis line by line
Most of the risk in a COA sits in seven places. Go through them in order.
Identity block. The certificate should carry the systematic name, the CAS number and the molecular formula together. A trade name on its own is not an identity. If your order used one synonym and the certificate uses another, check the CAS before you assume they match — in this family, several names describe the same structure and several similar names do not.
Assay, and the method behind it. A purity figure without a stated technique is not verifiable. Ask for the detection mode at minimum. For bile acids the point is not academic: these molecules have no usable chromophore, so the choice between refractive-index, UV, evaporative light-scattering and charged-aerosol detection changes what the number means.
Related substances, and the reporting threshold. This is the line buyers misread most often. "Impurity F: not detected" is a statement about the method's capability. Whether a peak could have been seen depends on the detection mode and the threshold applied to the batch. Two suppliers can issue honest non-detect results for the same material using different methods, and the two sheets say different things. We walked through this in more detail in our note on 7-ketolithocholic acid as an impurity of ursodeoxycholic acid.
Residual solvents. Ask which class of solvent is controlled and against which limit. Where they are controlled at all, that runs under the ICH Q3C framework. A certificate that omits the residual-solvent panel entirely is not necessarily wrong for an intermediate — but its absence should be stated, not glossed over.
Loss on drying, water content and heavy metals. Routine lines, and precisely because they are routine they are where copied specifications show up. If a specification sheet claims several pharmacopoeias at once, check that the values are not all drawn from one of them. We documented a live case of that in our comparison of EP and USP limits for ursodeoxycholic acid.
Microbiological data, for animal-derived material. Where the material is not sterile, ask what is tested. This is a line that generic checklists for synthetic APIs often do not mention at all.
Batch number, dates, and the batch field. Check the batch number, the manufacturing date and the retest date, and confirm they agree with the label and the packing list. A certificate template with the batch field left as a placeholder is not a document.
Animal-derived origin: the part most checklists skip
If the material is animal-derived, the sourcing statement carries as much weight as the analytical data, and it is the part a purely commercial supplier is least able to produce.
Ask for species, tissue and country of origin in writing, and ask how the source animals were raised and what they were medicated with. Then check consistency across the file: the species on the origin statement, the species implied by the product description, and the material described on the certificate should all be the same. Where a market imposes specific requirements on animal-derived materials, the applicable regulation sets the bar, and it is worth confirming which framework your market applies before you accept a generic statement.
None of this is paperwork for its own sake. It is the part of the file that a document-copying supplier cannot fake, which makes it a useful diagnostic.
Red flags worth acting on
- A specification sheet headed with several pharmacopoeias and populated with one. Multi-headed sheets with a single set of values are the most common artefact in this category.
- "EP grade" offered for a substance that has no monograph. The phrase has no meaning there, and its use tells you the supplier is not distinguishing the two cases.
- Impurity results reported as "not detected" with no reporting threshold. Unfalsifiable by construction.
- A purity figure quoted to two decimal places with no method. Precision is not the same as accuracy.
- A certificate issued on a trader's letterhead for material from an unnamed site. You cannot audit a site you are not told exists.
- Identical specification tables across unrelated suppliers. Once you have seen two of them, you stop trusting the tables and start reading the methods.
- A supplier who answers every question confidently, including the ones they cannot know. The confident answer to a question about the manufacturing route is often the wrong one.
What to ask before you order a sample
- What is the identity of the material — systematic name, CAS number and molecular formula, on one page?
- Is it supplied as a synthesis input or as a material controlled against another product's impurity specification?
- Which pharmacopoeia, if any, does the specification reference — and what are the values that come from it?
- What method produced each impurity figure, and what reporting threshold was applied?
- For animal-derived material: which species, which tissue, which country, and what does the origin statement say?
- What is in the residual-solvent panel, and on what basis are those limits set?
- Which documents come with the batch, and which require a request?
- Where the material is manufactured, and does the supplier name the site?
A supplier who can answer the first, fourth and fifth without a delay is telling you something. So is one who cannot.
Checking a supplier without visiting the site
Most buyers in this category will never audit a plant. That is normal, and it does not make verification impossible — it changes the method.
Ask for a batch history rather than a single certificate. One batch is a snapshot; a series shows whether anything varies. Request a sample and the certificate for that specific sample, then compare what arrives with what was described. Where a doubt remains, a third-party laboratory result on a retained sample answers more than correspondence will.
The most useful technique, in my experience, has nothing to do with documents. Pick one question you are fairly sure the supplier will find hard — for a trader, it is often a question about the actual manufacturing route or the site that produced the material. Then watch how the answer is handled. A supplier who says "I will find out and come back to you" and then does is worth more than one who produces a smooth answer on the spot.
That single behaviour predicts the rest of the relationship better than any checklist line, because it is the same instinct that decides whether you get told about a delay before you ask.
Frequently asked questions
How do I verify a bile acid supplier I found online?
Start with identity, not with reputation. Ask for the systematic name, CAS number and specification on one page, then ask which method produced each analytical figure. A supplier who can answer both, and who names the site where the material is made, has passed the first filter. One who references pharmacopoeial grades for a substance with no monograph has not.
What documents should come with a bile acid shipment?
At minimum, a batch-specific certificate of analysis, a label consistent with it, and packing documentation. On request, you should be able to obtain a specification sheet, a safety data sheet, residue-solvent information, an animal-origin statement where relevant, and traceability documentation. Which of these a given supplier can produce, and which they cannot, is itself part of the assessment.
Can a trading company be a legitimate bile acid supplier?
Yes. Trading companies are normal in this category, and a competent one can add real value — sourcing, consolidation, export documentation, and the ability to obtain paperwork from more than one site. What matters is that the role is stated. A trader who claims to be the manufacturer is a problem; a trader who names the site and can obtain that site's documents is a working partner.
Does a certificate of analysis prove quality?
It proves that certain tests produced certain results on a named batch. It does not prove the method was capable of detecting what it did not find, and it does not prove the batch in front of you is the batch on the sheet. Read the method column before you read the results column.
What is a TSE-BSE statement and do I need one?
It is a declaration about the animal-origin risk position of the material — species, tissue and geography — used to demonstrate that specified risk material has been avoided. If your material is animal-derived, you need one, and you should be able to reconcile it against the rest of the file. Where it does not exist, that is a fact about your supply chain, not a formality you can waive.
How do I know a supplier's specification is real?
You test it. Ask for the method behind the numbers, ask for a specific batch, and verify a sample independently. In this category a specification is a commercial statement until someone reproduces it — which is why the method matters as much as the value.
Summary
Verification in bile acids comes down to three questions, and none of them is about price. Is the identity unambiguous? Is each analytical number attached to a method? And is the sourcing chain for animal-derived material accounted for, or silent?
A supplier who answers all three, including the parts where the answer is "we cannot obtain that," is giving you something more useful than a complete document set: an accurate picture of where the gaps are. That is the thing worth paying for.
Send us the specification you are working to and the quantity you need. We will reply with what we can commit to, the documentation package we can supply with the batch, and the points where a document is not available — stated plainly. Use our quotation request page, or see how we structure supply.
Disclaimer. This article is published for technical and procurement reference by JAN Bio. It describes documentation practice and makes no claim about the use of any substance in the diagnosis, treatment, or prevention of disease, and contains no therapeutic, clinical, or dosing information. Regulatory requirements for animal-derived materials differ by market; confirm the framework applicable to your own jurisdiction and verify all acceptance criteria against your supplier's batch documentation. Document types described as available on request are subject to the manufacturing site's ability to provide them and will be confirmed in writing before order.